Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate by 源��듅�깮
Hepatitis C virus genomic RNA dimerization is mediated
via a kissing complex intermediate
SUMANGALA SHETTY,1 SEUNGTAEK KIM,2 TETSURO SHIMAKAMI,2 STANLEY M. LEMON,2
and MIHAELA-RITA MIHAILESCU1
1Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, USA
2Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch at Galveston,
Galveston, Texas 77555-0610, USA
ABSTRACT
With over 200 million people infected with hepatitis C virus (HCV) worldwide, there is a need for more effective and better-
tolerated therapeutic strategies. The HCV genome is a positive-sense; single-stranded RNA encoding a large polyprotein cleaved
at multiple sites to produce at least ten proteins, among them an error-prone RNA polymerase that confers a high mutation rate.
Despite considerable overall sequence diversity, in the 39-untranslated region of the HCV genomic RNA there is a 98-nucleotide
(nt) sequence named X RNA, the first 55 nt of which (X55 RNA) are 100% conserved among all HCV strains. The X55 region has
been suggested to be responsible for in vitro dimerization of the genomic RNA in the presence of the viral core protein, although
the mechanism by which this occurs is unknown. In this study, we analyzed the X55 region and characterized the mechanism by
which it mediates HCV genomic RNA dimerization. Similar to a mechanism proposed previously for the human immunode-
ficiency 1 virus (HIV-1) genome, we show that dimerization of the HCV genome involves formation of a kissing complex
intermediate, which is converted to a more stable extended duplex conformation in the presence of the core protein. Mutations
in the dimer linkage sequence loop sequence that prevent RNA dimerization in vitro significantly reduced but did not
completely ablate the ability of HCV RNA to replicate or produce infectious virus in transfected cells.
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INTRODUCTION
First identified in 1989 (Choo et al. 1989), it is now esti-
mated that hepatitis C virus (HCV), a blood-borne patho-
gen, persistently infects over 200 million people worldwide
(3% of human population) (Lindenbach et al. 2007; Paula
et al. 2009). A major cause of liver disease globally and the
leading cause of liver transplantation in North America,
chronic HCV infection is often associated with significant
liver disease, including cirrhosis and liver cancer (Brass et al.
2007; Qureshi 2007). Although as many as 50% of patients
with chronic genotype 1 HCV infection may be cured by the
current standard-of-care therapy with pegylated interferon-a
and ribavirin, many infected patients are either intolerant
of this treatment or fail to achieve a sustained viral response
(Hadziyannis et al. 2004; Muir et al. 2004).
HCV is an enveloped virus belonging to the Flaviviridae
family. Its genome is a 9.6-kb positive-sense RNA molecule
containing a long open reading frame (ORF), flanked by
highly structured and conserved 59- and 39-untranslated
regions (UTRs) (Fig. 1A; Lindenbach et al. 2005; Moradpour
et al. 2007). This ORF encodes a single polyprotein of
z3000 amino acids, which is proteolytically cleaved into at
least 10 structural and nonstructural viral proteins (Tan
et al. 2002). The nonstructural proteins are NS2, NS3,
NS4A, NS4B, NS5A, and NS5B, while E1, E2, p7, and the
capsid core protein constitute the structural proteins
(Penin et al. 2004). The nonstructural NS5B protein is an
error-prone RNA-dependent RNA polymerase, which re-
sults in a high mutation rate during replication of the virus
(Penin et al. 2004; Moradpour et al. 2007).
The 59- and 39-UTRs contain cis-acting elements that are
crucial for RNA replication and translation (Ito and Lai
1997; Song et al. 2006). The 341-nucleotide (nt) 59-UTR is
a complex, four-domain structure that contains an internal
ribosome entry site (IRES), which directs cap-independent
translation of the ORF, as well as upstream signals required
for viral RNA synthesis (Tsukiyama-Kohara et al. 1992;
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Wang et al. 1993). The 225-nt 39-UTR has a tri-domain
organization, with a nonconserved 40-nt variable region, a
poly (U/UC) stretch of 20–200 nt, and a 39-terminal, con-
served 98-nt sequence named X-RNA (Fig. 1A; Kolykhalov
et al. 1996; Blight and Rice 1997).
The 39 X RNA region is essential for RNA replication and
may also facilitate viral protein translation directed by the
viral IRES (Song et al. 2006; You and Rice 2008). As shown
in Figure 1B, there are two alternate conformations pre-
dicted for the 39-UTR sequence when analyzed by the MFold
program (Ivanyi-Nagy et al. 2006). Both predicted confor-
mations include the formation of the extreme 39 terminal
SL1 stem–loop; however, they differ with regard to the
folding of a 55-nt-long upstream segment, which we name
the X55 RNA region in this study. Two stem–loops (SL2
and SL3) are present within the X55 region in one pre-
dicted conformation (‘‘SL2’’ and ‘‘SL3’’) (Fig. 1B, left),
whereas an extended single stem–loop containing internal
bulges is present in the second (Fig. 1B, right). While chem-
ical probing data and mutational analysis both support the
existence of the 39SL1 stem–loop at the extreme 39-end
(Blight and Rice 1997; Yi and Lemon 2003a; Dutkiewicz
and Ciesiolka 2005), the structure adopted by the X55 RNA
region (which is 100% conserved in its sequence among
different HCV strains) remains controversial. No homolo-
gous sequences have been found in related viruses, in
phylogenetically distinct viruses, or in cellular mRNAs
(Dutkiewicz and Ciesiolka 2005). While the reasons un-
derlying the extraordinarily high level of sequence conser-
vation within the unique X55 region is unknown, it is likely
due, at least in part, to the need to
maintain higher ordered RNA struc-
tures required for essential processes in
the viral life cycle.
Previous studies suggest that the X55
region is involved in long-range kissing
interactions with a conserved stem–
loop located in the NS5B coding region,
which resides at the 39 end of the ORF
(named 5BSL3.2) (Friebe et al. 2005;
Diviney et al. 2008; You and Rice 2008).
The biological significance of these in-
teractions has been proven in the con-
text of subgenomic HCV RNA repli-
cons, as well as in a recently developed
system allowing for production of in-
fectious HCV in cell cultures (You and
Rice 2008); mutations in either of the
involved stem–loops (5BSL3.2 or X
RNA SL2) that altered the complemen-
tarity of the sequences involved in the
proposed kissing loop interactions led
to a complete block of RNA replication,
while complementary mutations re-
stored this function.
Interestingly, the same X55 region contains a 16-nt pal-
indromic sequence, which has been suggested to be re-
sponsible for homodimerization of the HCV RNA in vitro
in the presence of the HCV core protein (Fig. 1B, highlighted
in red; Ivanyi-Nagy et al. 2006). This 16-nt palindromic
HCV sequence was named the dimer linkage sequence
(DLS), in analogy to a sequence with similar function in
human immunodeficiency virus type 1 (HIV-1) (Ivanyi-
Nagy et al. 2006). The mechanism by which homodimers of
the HCV genome might form is unknown. Moreover, the
biological significance of the homodimerization of the ge-
nome and its relevance to the HCV life cycle have yet to be
established. The finding that the HCV genome dimerizes in
vitro is surprising. Dimerization of genomic RNA is com-
mon to the Retroviridae, where it allows two copies of the
genome to be encapsidated in the virion (Kung et al. 1976;
Bender et al. 1978; Maisel et al. 1978; Murti et al. 1981).
However, this is not known to occur in the Flaviviridae
family, and the HCV virion is believed to contain a single
copy of the genomic RNA. Thus, dimerization of the HCV
genome, if it occurs within infected cells (as it does in vitro
in the presence of the core protein), is likely to play a
different role in the viral life cycle.
Here, we have studied the mechanism by which the
highly conserved HCV X55 region mediates the dimeriza-
tion of the HCV genome. We show that this process
involves the formation of a homodimeric kissing complex
intermediate involving the HCV DLS region, and that this
is converted to a more stable extended duplex by the viral
core protein. Since the involvement of the DLS region in
FIGURE 1. (A). Schematic representation of HCV genome. (B) Alternate predicted confor-
mations of X RNA obtained by Mfold. The DLS region is highlighted in red. The mutations
introduced in the X98_G30_31AP are shown in blue and red, respectively.
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this process would preclude its ability to
engage in the long-range kissing interac-
tion with the NS5B-coding region that
is known to be essential for RNA rep-
lication, we propose that the DLS region
might have dual, mutually exclusive
functions in defining alternative con-
formations of the 39X RNA. These al-
ternate conformations may constitute
a molecular switch that directs plus-
strand genomic RNA from RNA syn-
thesis to packaging, and eventually to
cellular export.
RESULTS AND DISCUSSION
HCV RNA dimerization occurs via a kissing complex
intermediate
The HCV X RNA region has been shown to be involved in
the in vitro homodimerization of HCV genomic RNA in
the presence of the viral core protein (Ivanyi-Nagy et al.
2006). This is an interesting result considering that a role
for genomic RNA dimerization has thus far been described
only in the life cycle of retroviruses (Kung et al. 1976;
Bender et al. 1978; Maisel et al. 1978; Murti et al. 1981).
The sequence responsible for HCV RNA dimerization is
a 16-nt palindrome within X RNA (Fig. 1B, highlighted in
red), named DLS in analogy with the DLS sequence of
HIV-1, which is a 23-nt palindrome that has been shown to
have a major role in the selection of the copackaged RNA
partner in the HIV-1 virion in vivo (Moore et al. 2007). In
HIV-1, genomic RNA dimerization initially involves the for-
mation of a kissing complex intermediate via the Watson–
Crick pairing of the DLS, which is converted to an extended
duplex in the presence of the HIV-1 nucleocapsid (NC)
NCp7 protein (Rist and Marino 2002; Mihailescu and
Marino 2004). A similar mechanism of RNA genomic di-
merization has been demonstrated for the murine leukemia
virus, and this has been proposed to be a general feature of
other members of the Retroviridae, including viruses such as
avian leucosis sarcoma virus and Mason-Pfizer monkey virus
(Aagaard et al. 2004).
Given the previous report of HCV RNA dimerization
(Ivanyi-Nagy et al. 2006), we asked whether a mechanism
of dimerization similar to that taking place in Retroviridae
might also occur in the case of HCV, a member of the
Flaviviridae family. Specifically, we considered the possi-
bility that HCV dimerization might involve the initial
formation of a kissing complex intermediate engaging its
DLS region, in the absence of the core protein (Fig. 2, top),
which in the presence of the core protein is converted to
a more stable, extended duplex conformation (Fig. 2,
bottom). Since the structure adopted by the first 55 nt of
the X RNA segment of HCV (which includes the 16-nt DLS
sequence) is uncertain, we designed a series of experiments
to test this hypothesis using the entire 55-nt segment,
which will be referred to here as X55 RNA.
Native gel electrophoresis studies
The formation of RNA kissing complexes requires Mg2+
ions (Marquet et al. 1991; Ohuchi and Nakamura 2007).
Thus, the first step in testing the above hypothesis was to
investigate the conformational status of X55 RNA, whether
it exists as a monomer or dimer in the absence of Mg2+
ions, and subsequently to determine if X55 RNA dimerizes
in the absence of the core protein and in a MgCl2-
dependent manner. In the absence of Mg2+ ions, X55
RNA is monomeric, as evidenced by its migration pattern
on a native TBE gel (Fig. 3A, left panel). However, as shown
in Figure 3A, at MgCl2 concentrations in the range of 1–10
mM, there are two bands present on a native TBM gel of
X55 RNA, with the monomer band that is most intense in
the presence of 1 mM MgCl2 (Fig. 3A, right panel, lane 1)
decreasing in intensity with a concomitant increase in in-
tensity of the dimer band at 5 mM MgCl2 (Fig. 3A, right
panel, lane 2) and 10 mM MgCl2 (Fig. 3A, right panel, lane 3).
While this result indicates that the X55 dimer concentra-
tion increases with increasing MgCl2 concentrations, it does
not prove unambiguously the existence of an X55 kissing
complex dimer, as both the kissing complex and the duplex
conformations are dimeric (Fig. 2) and should migrate
similarly on a native TBM gel. However, since the kissing
complex conformation depends on the presence of Mg2+
ions, it should dissociate into monomers while migrating
through a TBE gel in which these ions are chelated by
EDTA (Mujeeb et al. 2007). In contrast, once formed, the
duplex conformation will not be affected, as this confor-
mation is not dependent on the presence of Mg2+ ions.
Thus, to distinguish between these two potential X55 RNA
dimeric conformations (kissing complex versus duplex), we
ran two parallel gels, one in TBM that contained 10 mM
MgCl2 and one in TBE in which the Mg
2+ ions are chelated
FIGURE 2. Model for the kissing complex formed by the X55 RNA (top) and its proposed
conversion into the more thermodynamically stable duplex conformation (bottom) in the
presence of the core 2BD peptide. The two X55 RNA molecules are identical, but they are
illustrated in different colors for clarity purposes.
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(Fig. 3B). X55 RNA was snap-cooled and upon the addition
of 10 mM MgCl2, two sets of samples were prepared: the
first set was incubated at 22°C (temperature at which the
kissing complex conformation is maintained) for 2.5 h,
whereas the second set was incubated for 2.5 h at 55°C
(temperature that promotes the conversion of any kissing
complex to the duplex conformation) (Mujeeb et al. 2007).
As seen in Figure 3B, in a TBM gel two bands, monomer
and dimer (kissing complex), are present in Figure 3B, right
panel, lane 2, which contains the X55 RNA sample in-
cubated at 22°C; whereas, as predicted, a single dimeric
band (duplex) is present in the X55 RNA sample incubated
at 55°C (Fig. 3B, right panel, lane 1). In contrast, in a TBE
gel, in which the Mg2+ ions are chelated by EDTA, the
dimer band of the X55 RNA incubated at 22°C is greatly
diminished with a concomitant increase in the intensity of
the monomer band (Fig. 3B, left panel, lane 2), indicating
the dissociation of the kissing complex. As expected, the
dimer band corresponding to the X55 RNA incubated at
55°C was not changed during passage through the TBE gel
(Fig. 3B, left panel, lane 1), since the duplex conformation
is not affected by the absence of the Mg2+ ions. These
results strongly support the existence of a kissing complex
dimer intermediate formed by the X55 HCV RNA, in the
absence of the core protein. These results differ from the
previous description of HCV RNA dimerization, which
suggested that this does not involve kissing dimer in-
termediates formed in the absence of the viral core protein
(Ivanyi-Nagy et al. 2006). This difference is likely due to the
fact that micromolar RNA concentrations were used in our
native gels, as opposed to the picomolar concentrations
used in previous studies (Ivanyi-Nagy et al. 2006). For a
dimer complex with a dissociation constant in the nano-
molar range (see below) (Fig. 4), the dimer species is
negligible when the total RNA concentration used in the
dimerization assay is in the picomolar range.
Fluorescence spectroscopy studies
To obtain quantitative information about the kissing
complex intermediate formed in the HCV RNA dimeriza-
tion process, we used a fluorescence spectroscopy assay
initially developed to characterize HIV-1 RNA dimerization
(Rist and Marino 2002; Mihailescu and Marino 2004). In
this assay, the highly fluorescent purine analog 2-amino
purine (2AP) replaces the adenine in the CUAG DLS
hairpin loop (at position 31 in X55 RNA) (shown in red
in Fig. 4A). The 2-AP steady-state fluorescence is very
sensitive to its microenvironment, being quenched by
stacking interactions (Heppell et al. 2009). Thus, if a kissing
complex is formed by X55 RNA in the presence of MgCl2,
the steady-state fluorescence of the 2AP reporter will be
quenched due to the change in its microenvironment from
a single-stranded loop nucleotide (Fig. 4A, top) to a base-
paired stacked nucleotide in the kissing complex (Fig. 4A,
bottom). To ensure that a single 2AP reporter is present in
the HCV X55 kissing complex, we designed an X55 RNA
construct in which the A at position 31 in the CUAG DLS
loop sequence was replaced by C (named X55_C31) (Fig.
4A). To maintain the complementary base pairs in the DLS
loop, we replaced the U at position 30 in the CUAG DLS
loop with G, thus generating X55_G30_31AP (Fig. 4A).
This type of loop sequence alteration to construct hetero-
dimers has been previously employed in the studies of the
HIV-1 dimerization for both, the Lai variant (Paillart et al.
1996, Takahashi et al. 2000), and Mal variant (Rist and
Marino 2002; Mihailescu and Marino 2004). We used TBM
native gel electrophoresis to demonstrate that neither
X55_G30_31AP, nor X55_C31 RNA is able to form
homodimers due to their mismatched loop sequences
(Fig. 4B, lanes 1,2), whereas they form dimers when mixed
in equimolar ratios (Fig. 4B, lane 3), similar to those
formed by the wild-type X55 RNA (Fig. 4B, lane 4).
The titration of the labeled X55_G30_31AP RNA (500 nM
in 1 mM cacodylic acid at pH 6.5 and 10 mM MgCl2) with
nanomolar increments of the complementary unlabeled
construct, X55_C31 RNA, resulted in a decrease in the
fluorescence emission at 371 nm (Fig. 4C, blue triangles),
FIGURE 3. (A, right) TBM native gel of X55 RNA (20 mM) at
different MgCl2 concentrations: 1 mM (lane 1), 5 mM (lane 2), and 10
mM (lane 3). Both the gel and the running buffer contained 1 mM
MgCl2. (Left) TBE native gel with no magnesium: Abnova RNA
marker R0001 (lane 1) and wild-type X55 RNA (lane 2). (B, right)
TBM gel containing 10 mM MgCl2. Both lanes contain X55 RNA
annealed, treated with 10 mM MgCl2 and incubated for 2.5 h at 55°C
(lane 1) and 22°C (lane 2), respectively. (Left) TBE native gel with no
magnesium. Both lanes contain X55 RNA annealed, treated with 10
mM MgCl2 and incubated for 2.5 h at 55°C (lane 1) and 22°C (lane
2), respectively.
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due to the base stacking interactions arising when the 2AP
in the labeled RNA (X55_G30_31AP) and the uracil in the
unlabeled complementary RNA construct (X55_C31) be-
come involved in base pairs (Fig. 4A). This interpretation is
supported by the results of a control experiment that
demonstrated that when a mutated X55 RNA with the
sequence CAAG in the DLS loop (X55_A30_A31) was
titrated into X55_G30_31AP, the 2AP fluorescence of
FIGURE 4. (A) RNA samples used in the fluorescence spectroscopy assay to detect kissing complex formation (the samples were 55 nt, but only
the DLS region with the indicated mutations highlighted in red, blue, and green is shown [top]) and their proposed kissing interactions (bottom).
(B) TBM native gel showing that neither X55_G30_31AP RNA (lane 1) nor X55_C31 RNA (lane 2) is able to homodimerize in the presence of 10
mM MgCl2, but they heterodimerize when mixed (lane 3), similar to the wild-type X55 RNA (lane 4). (C) Plots of the steady-state fluorescence of
X55_G30_31AP (500 nM) in 1 mM cacodylic acid (pH 6.5) and 10 mM MgCl2, titrated with nanomolar increments of X55_C31 RNA (blue
triangles), with a mutant RNA X55_A30_A31, which contains a CAAG loop as opposed to the wild-type CUAG loop (black squares), or with a 21-nt
fragment derived from EF1A mRNA (red circles). (D) Plot of the steady-state fluorescence of the full-length X98_G30_31AP RNA (500 nM) in
1 mM cacodylic acid (pH 6.5) and 10 mM MgCl2, titrated with nanomolar increments of X55_C31. (E) Plot of the steady-state fluorescence of
X55_G30_31AP (500 nM) in 1 mM cacodylic acid (pH 6.5) and 10 mM MgCl2, titrated with nanomolar increments of DLS_C9 RNA.
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X55_G30_31AP did not change significantly (Fig. 4C, black
squares), as the noncomplementarity of the DLS loops of
these two RNAs prevents the formation of a kissing
complex. Similarly, no significant decrease in the 2AP
reporter signal was observed in a second control experi-
ment in which an unrelated single-stranded RNA derived
from the EF1A mRNA was titrated into X55_G30_31AP
(Fig. 4C, red circles).
The binding curve of X55_C31 was fitted with Equation
1 (Materials and Methods) to determine the dissociation
constant for the heterodimeric kissing complex formed by
X55_G30_31AP and X55_C31 as 318 6 58 nM (Fig. 4C,
blue triangles). The mutated terminal loop HCV DLS
sequences used in the determination of this dissociation
constant potentially could create RNA structure interac-
tions that differ subtly from those of the native sequence.
Nonetheless, this value determined by fluorescence spec-
troscopy provides an upper limit for the dissociation
constant of the kissing complex formed by the wild-type
X55 RNA, as the wild-type RNA appears to form tighter
kissing homodimers than the heterodimeric kissing dimers
formed by X55_G30_31AP and X55_C31 (Fig. 4B, cf.
relative intensities of monomer/dimer bands in lanes 3
and 4 of the native TBM gel Fig. 4B). It is noteworthy that
this value is in the same range as the dissociation constant
of 200 nM determined for the HIV-1 DLS kissing complex
(Zhao and Marino 2007) and for other RNA kissing
complexes (Argaman and Altuvia 2000; Di Primo 2008).
With respect to the biological relevance of these results, it is
important to consider that the replication of HCV RNA, as
with other positive-strand RNA viruses, is directed by
membrane-associated replication complexes. In the case
of HCV, these appear as ‘‘membranous webs,’’ composed
of vesicles 80–180 nm in diameter (Egger et al. 2002; Gosert
et al. 2003; Wolk et al. 2008). The local concentration of the
genomic RNA within this microenvironment, while un-
known, may be quite high, potentially reaching levels
sufficient for the formation of a homodimeric kissing
complex with a dissociation constant in the nanomolar
range.
To exclude any possibility of dimerization artifacts due
to truncation of the 39 X RNA sequence in the X55
constructs, we also analyzed the dimerization properties
of the full-length 98-nt X RNA. To accomplish this, we
constructed a 98-nt X RNA that, like X55, had the A at
position 31 replaced by 2AP and the U at position 30
replaced by G (X98_G30_31AP) (indicated in Fig. 1B,
right), and analyzed its dimerization with X55_C31 RNA.
By fitting the binding curve of X98_G30_31AP to Equa-
tion 1 (Fig. 4D), we determined a dissociation constant of
323 6 16 nM. The fact that the dissociation constants de-
termined for X55_G30_31AP and full-length X RNA
X98_G30_31AP are the same (within experimental error)
suggests that the truncated X55 RNA mimics the behavior
of the full-length X RNA, and validates the selection of X55
RNA as a useful model for the analysis of the X RNA
homodimerization process.
We also asked whether X55 RNA is able to dimerize with
the isolated 16-nt DLS sequence, which due to its size, is
expected to fold as a simple stem–loop–hairpin (Fig. 1B,
right, highlighted red sequence). For this, we constructed
a 16-nt DLS that had the A at position 9 (equivalent to
position 31 in X55 RNA and full-length X RNA) in the
CUAG loop mutated to C (DLS_C9) to maintain loop
complementarity with X55_G30_31AP. We determined the
dissociation constant for the kissing complex formed
between X55_G30_31AP and the 16-nt DLS_C9 to be 188 6
33 nM (Fig. 4E). This value is in the same range as the
dissociation constants determined for the X55_G30_31AP:
X55_C31 and X98_G30_31AP: X55_C31 kissing com-
plexes, corresponding to a difference in free energy of
kissing complex formation of only 0.3 kcal/mol. This result
suggests that, when participating in the formation of
homodimeric kissing complex interactions between two X
RNA molecules, the DLS region adopts a stem–loop
conformation as depicted in Figure 1B, right. However, it
should be noted that this finding does not rule out the
existence of alternative conformations of X55 RNA, which
would make possible its long-range interactions with the
5BSL3.2 hairpin.
The HCV core protein 2BD domain converts
the X55 kissing complex intermediate to a more stable
duplex conformation
The HCV core protein is a 191 amino acid, highly basic,
RNA binding protein with a hydrophilic N terminus
(containing three basic domains) and a hydrophobic C
terminus (Cristofari et al. 2004). The core protein acts as
a building block of the viral NC and together with the
envelope glycoproteins forms the structure of the infectious
virion (Ivanyi-Nagy et al. 2006; Brass et al. 2007; Qureshi
2007). The core protein has RNA-binding and nucleic acid
chaperone properties (Ivanyi-Nagy et al. 2006), similar to
those found in retroviral NC proteins (Tsuchihashi and
Brown 1994; Lapadat-Tapolsky et al. 1995; Rein et al. 1998;
Bampi et al. 2004; Levin et al. 2005). Since it has been
shown that the full-length HCV core protein and its
isolated basic domains (either alone or in combination)
have similar nucleic acid chaperoning ability, we used
a synthetic peptide (2BD) representing a fusion of the first
two basic domains of core, comprising residues 2–23 and
38–74 (Ivanyi-Nagy et al. 2006) to examine the role of this
protein in X RNA dimerization.
As described above, previous studies with HIV-1 RNA
suggest by analogy that the kissing complex intermediate
formed by the HCV X55 RNA might be converted to a
more thermodynamically stable extended duplex confor-
mation by the core 2BD peptide (Fig. 2). To test this hy-
pothesis, we initially used native TBM gel electrophoresis:
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The core 2BD peptide was directly added to the preformed
wild-type X55-X55 kissing complex, and following incuba-
tion for 0.5 h, proteinase K was added to the samples to
degrade the 2BD core peptide. As shown in Figure 5A, the
addition of the 2BD core peptide caused X55 RNA, which
in the absence of the peptide exists as a mixture of
monomer and dimer (Fig. 5A, right panel, lane 1), to exist
only in the dimer conformation (Fig. 5A, right panel, lane
3). This dimer migrated at the same position as the control
X55 duplex obtained by incubating the X55 RNA in the
presence of 10 mM MgCl2 for 2.5 h at 55°C (Fig. 5A, right
panel, lane 2). To determine whether the X55 conformation
obtained after addition of the 2BD core peptide was indeed
the duplex conformation, we used TBE native gel electro-
phoresis. As seen in Figure 5A, in the presence of EDTA,
which chelates Mg2+ ions, X55 RNA incubated in the ab-
sence of the 2BD peptide at 22°C reverts to the monomeric
state (Fig. 5A, left panel, lane 1). In contrast, neither the
X55 sample incubated in the presence of the 2BD core
peptide (Fig. 5A, left panel, lane 3) nor the control duplex
X55 RNA obtained by incubation at 55°C for 2.5 h (Fig. 5A,
left panel, lane 2) was affected by EDTA. This result in-
dicates that the core 2BD peptide is able to act on the X55
RNA to promote its structural isomerization to the duplex
conformation.
To elucidate the mechanism of this structural isomeri-
zation, we used a fluorescence spectroscopy assay similar to
that previously employed for the study of the HIV-1 dimer
initiation site (Rist and Marino 2002; Mihailescu and
Marino 2004). We constructed two additional X55 RNA
molecules: X55_G30_52AP, which retains the (U/G) at
position 30 (Fig. 5B, shown in blue) and has 2AP inserted
in the lower stem region at position 52 (Fig. 5B, shown in
red) to form a single nucleotide bulge; and X55_C31_U5,
which retains the point mutation (A/C) at position 31
(Fig. 5B, shown in blue) and has a uracil inserted in the
lower stem at position 5 (Fig. 5B, shown in red). Due to the
G30 and C31 mutations, these two X55 molecules have
their DLS loops mismatched and are not able to homodi-
merize, but they can heterodimerize when mixed in an
FIGURE 5. (A, right) TBM native gel: X55 RNA samples (20 mM) were annealed and treated with 10 mM MgCl2, followed by incubation at 22°C
(lane 1), incubation at 55°C (lane 2), and incubation at 22°C and treatment with 1:2 RNA: core 2BD peptide (lane 3). (Left) TBE native gel: X55
RNA samples (20 mM) were annealed and treated with 10 mM MgCl2, followed by incubation at 22°C (lane 1), incubation at 22°C, and treatment
with 1:2 RNA: core 2BD peptide (lane 2) and incubation at 55°C (lane 3). (B) RNA samples used in the fluorescence spectroscopy assay used to
detect the kissing complex to duplex structural isomerization. The inserted 2AP and uracil are highlighted in red, and the loop mutations are
highlighted in blue. (C) TBM native gel showing that neither X55_G30_52AP RNA (lane 1) nor X55_C31_U5 RNA (lane 2) is able to
homodimerize, but they heterodimerize when mixed in equimolar ratio (lane 3), similar to the wild-type X55 RNA (lane 4). (D) Conversion of
the kissing complex conformation to duplex by the 2BD core peptide (black triangles). The curve was fit with equation 2 (Materials and Methods)
to determine the structural isomerization rate. Blue squares indicate that the addition of the 2BD core peptide in the absence of MgCl2 does not
quench the 2AP fluorescence. Red circles indicate that no structural isomerization occurs in the absence of the core 2BD peptide.
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equimolar ratio, as shown when analyzed in a native TBM
gel (Fig. 5C). The steady-state fluorescence of the 2AP in
X55_G30_52AP is expected to be high when this RNA is
involved in a kissing complex with X55_C31_U5 due to its
internal bulge conformation (Fig. 5B, top). If the core
protein converts the kissing complex to the stable duplex
conformation by a strand exchange mechanism, the 2AP in
X55_G30_52AP will base pair with the uracil at position
5 of X55_C31_U5, and since this newly formed 2AP-U base
pair (Fig. 5B, shown in red) will become part of the
extended duplex, the steady-state fluorescence of the 2AP
in X55_G30_52AP will be quenched over time due to
stacking interactions.
As shown in Figure 5D, this was indeed the case, as an
80% decrease in the 2AP steady-state fluorescence was ob-
served upon the addition of an excess of 2BD core peptide
to the preformed kissing complex between X55_G30_52AP
and X55_C31_U5 in the presence of 10 mM MgCl2 (Fig.
5D, black triangles). This result indicates that the 2BD core
peptide assists in the conversion of the kissing complex
intermediate to the duplex conformation by a strand-
exchange mechanism, similar to the mechanism reported
for the NCp7-chaperoned structural isomerization of the
HIV-1 RNA genome (Rist and Marino 2002; Mihailescu
and Marino 2004). To rule out the possibility that the
observed quenching could be due to the direct interactions
of the core 2BD peptide with the 2AP reporter and not
the strand-exchange mechanism, we carried out a control
experiment in which the same excess of the core 2BD
peptide was added to a mixture of X55_G30_52AP and
X55_C31_U5, but in the absence of MgCl2. As shown in
Figure 5D (blue squares), this led to an initial 10% drop in
the 2AP steady-state fluorescence, which over time returned
to the 100% intensity value, in contrast to the drop in in-
tensity associated with the conversion of the kissing complex
to the duplex conformation (Fig. 5D, black triangles).
This result also indicates that the kissing complex
conformation is required for the core 2BD peptide activity,
as in the absence of Mg2+ ions (conditions in which the
kissing complex does not form), the peptide cannot convert
X55_G30_52AP and X55_C31_U5 to the dimer conforma-
tion. This result was confirmed by native gel electrophore-
sis of the wild-type X55 RNA, in which no dimer band was
observed in the absence of Mg2+ ions despite an excess of
the 2BD peptide (data not shown). Thus, it is likely that
when assisting in the structural isomerization of the HCV
DLS, the core protein does not employ a ‘‘zipper’’ pathway
involving nucleation at the 39-/59-terminal ends, such as
the HIV-1 NCp7 protein has been suggested to use in
annealing of the full-length transactivation response ele-
ment (TAR) (Vo et al. 2009). Also shown in Figure 5C is
the result of a second control experiment, in which we
confirmed that in the absence of the core 2BD protein, the
steady-state fluorescence of X55_G30_52AP, which is in-
volved in a kissing complex with X55_C31_U5 in the
presence of 10 mM MgCl2, remains almost constant over
time (Fig. 5D, 5% drop in intensity, red circles). This
indicates that within the timeline of the experiment,
conversion to the duplex conformation is minimal without
the assistance of the 2BD core peptide. The rate of con-
version from the kissing complex to the duplex conforma-
tion, kconv, was obtained by fitting the conversion curve
(Fig. 5D, black triangles) with Equation 2 (Materials and
Methods). The value of kconv = 1.7 6 0.2 min
1 is very
similar to that of kconv = 2.2 6 0.2 min
1, reported for the
conversion rate of the HIV-1 DLS kissing dimer to the
mature extended duplex by the NCp7 protein (present in
a 5:1 ratio, as in our experiments).
Taken together, these results indicate that the mecha-
nism of HCV RNA dimerization involves the formation of
a kissing complex intermediate, which in the presence of
the core peptide undergoes isomerization through the
melting of intramolecular stem base pairs and reformation
of intermolecular base pairing to form a more thermody-
namically stable duplex conformation. These results thus
demonstrate a remarkable similarity in the mechanisms of
genomic RNA dimerization of HCV and HIV-1.
Possible biological role of HCV genomic RNA
dimerization
We have shown unambiguously that the mechanism by
which genomic HCV dimerization occurs in vitro is very
similar to that of HIV-1, involving the formation of a
kissing complex intermediate that is converted to a duplex
conformation by the basic core protein. Despite these
similarities, the finding that the HCV RNA genome di-
merizes in vitro is very surprising. Unlike HIV-1, HCV
genomic RNA is generally believed to be packaged in viral
particles as a monomer (although this has never been
formally demonstrated). This suggests that dimerization of
the HCV genome may play a completely different role in
the life cycle of the virus. To explore a possible role for
HCV genomic RNA dimerization in virus replication, we
determined whether mutations in the DLS loop sequence
that prevent the RNA dimerization in vitro have any effect
upon the replication capacity of HCV RNA in transfected
cells (Yi and Lemon 2003b). For these studies, we trans-
fected cells with a modified, genome-length, genotype 1a
HCV RNA in which the sequence encoding Gaussia lu-
ciferase (GLuc) was inserted in-frame into the viral poly-
protein-coding region of an infectious molecular clone
(H77Sv3; see Materials and Methods). Three different
mutations were introduced into the 39-UTR sequence of
this modified viral RNA, replacing the CUAG wild-type
DLS loop sequence with CUUG (DLS_UU), CAAG
(DLS_AA), and CAUG (DLS_AU). It was expected that
the mutations in the DLS_UU and DLS_AA would prevent
RNA dimerization due to their mismatched loops, whereas
although not wild type, the DLS_AU sequence would retain
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the ability to dimerize since its mutations are compensa-
tory. To test this hypothesis, related X55 sequences con-
taining identical mutations in the DLS loops were prepared
in vitro by transcription reactions off synthetic DNA
templates (X55_UU, X55_AA and X55_AU). As showed
by native TBM gel electrophoresis (Fig. 6A), the X55_UU
and X55_AA were not able to dimerize (Fig. 6A, lanes 3,4),
whereas X55_AU formed dimers (Fig. 6A, lane 2). It is
interesting to note that although these mutated X55 RNAs
behaved as expected with respect to the formation of the
kissing complex dimer, the migration pattern of their
monomeric form differed from that of the wild-type X55
(Fig. 6A, lanes 1,2), suggesting that they might adopt dif-
ferent conformations (whereas this was not the case with
the mutated X55 samples used in the fluorescence spec-
troscopy studies).
The impact of the DLS mutations upon HCV RNA
replication was assessed by measuring GLuc activity in cell
culture media following transfection with genome-length
RNAs containing the wild-type DLS (v3 WT), a negative-
control RNA with a replication-lethal mutation in the
active site of the NS5B RNA-dependent RNA polymerase
(v3/AAG), or RNAs with mutated DLS sequences: DLS_AA,
DLS_UU and DLS_AU. The GLuc activities were normal-
ized to that present at 9 h following transfection, to control
for variations in transfection efficiency, with the relative
GLuc activity at 24, 48, 72, 96, and 120 h taken as a measure
of genome amplification. As shown in Figure 6B, left panel,
RNA containing the wild-type DLS (v3 WT) demonstrated
robust replication, with a 175-fold increase in secreted GLuc
activity by 120 h after transfection, whereas the negative-
control v3/AAG RNA containing a lethal polymerase muta-
tion demonstrated a >90% decline in GLuc activity consis-
tent with a failure to replicate and express the polyprotein.
The DLS_AA and DLS_UU mutations both partially
inhibited but did not ablate replication of the viral RNA.
The DLS_UU mutant replicated with moderate efficiency,
demonstrating an approximately 40-fold increase in GLuc
activity between 9 and 120 h after transfection, while the
DLS_AA mutant was severely impaired for replication,
generating only a 2.5-fold increase in GLuc activity. Both
mutants demonstrated substantial delays in the replication
kinetic, with increases in GLuc not observed until after 48 h,
z24 h later than wild type (Fig. 6B). Importantly, the
double compensatory mutations in DLS_AU failed to rescue
RNA replication, as might have been expected if the RNA
dimerization were essential for RNA replication. In contrast,
the impact of the double mutations appeared to be additive,
giving rise to a near-lethal RNA replication phenotype and
GLuc activities minimally above background at 120 h.
The DLS mutations were also placed directly into the
background of the parental genotype 1a infectious molec-
ular clone (H77Sv3) that was used for construction of the
GLuc RNAs described above. H77Sv3 RNA is capable of
producing fully infectious virus particles when transfected
into cells (Yi et al. 2006), allowing an assessment of the
effect of DLS mutations on viral assembly and release.
Supernatant fluids were collected from RNA-transfected
cells 96 h after transfection, and the yield of virus was
determined by an infectious focus assay following inocula-
tion of naı¨ve cells, as described previously (Yi et al. 2006).
In replicate experiments, the presence of the DLS_UU
mutation resulted in an 89% 6 7% reduction in infectious
virus yield relative to the wild-type RNA. This reduction is
consistent with the impairment in RNA replication (77%)
demonstrated by the DLS_UU mutant in Figure 6B. The
severely attenuated replication phenotypes of the DLS_AA
and double DLS_AU mutants precluded testing of their
ability to produce infectious particles.
FIGURE 6. (A) Native TBM gel showing that wild-type X55 RNA (lane
1) and its DLS loop mutated constructs: the double mutant (DLS_AU)
with compensatory mutations can homodimerize (lane 2), whereas the
single mutants—DLS_UU (lane 3) and DLS_AA (lane 4) —are not able
to homodimerize due to their mismatched loops. (B, left) Normalized
GLuc activity in culture supernatants collected at different times after
transfection of cells with replication competent genome-length HCV
RNA with a wild-type DLS (v3 WT, u), a negative-control RNA with
defective RNA-dependent RNA polymerase activity (v3/AAG, j), and
related DLS-mutant RNAs: DLS_AA (s), DLS_UU (4), and
DLS_AU (e). (Right) Yield of infectious virus released into superna-
tant fluids of cell cultures transfected with the H77Sv3DLS-UU viral
RNA. Virus titers were determined by an infectious focus assay and
are reported relative to that released by cells transfected in parallel
with the wild-type H77Sv3 RNA (100%). Error bars, range of results
obtained in replicate independent experiments.
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The fact that the DLS_UU and DLS-AA mutants are
incapable of dimerization in vitro, yet capable of at least
limited replication, suggests that dimerization of the geno-
mic RNA is not absolutely essential for viral RNA replica-
tion. While rescue of the replication defects in DLS_AA
and DLS_UU by the double compensatory mutations in
DLS_AU would have suggested that dimerization facilitates
efficient RNA replication, the absence of such a result
cannot be considered to exclude this possibility. Given the
high degree of conservation of the DLS sequence, it is
possible that the loss of RNA replication competence in the
mutated DLS constructs could have reflected perturbation
of essential interactions other than dimerization of the
RNA (including, for example, the kissing-loop interaction
with the upstream NS5B sequence) (Friebe et al. 2005;
Diviney et al. 2008; You and Rice 2008). Previous studies
have shown that very few mutations introduced into the
first 55 nt of X55 RNA are tolerated, and with a single
exception, those that do not ablate replication of the RNA
are located outside the DLS region (Yi and Lemon 2003b).
The results of the infectious RNA experiments also suggest
that dimerization of the genome is not absolutely essential
for other aspects of the viral life cycle, including packaging
of the viral RNA during virion assembly.
As mentioned earlier, it has been proposed that a frag-
ment of the HCV DLS sequence (Fig. 1B, nucleotides 32–
38) is involved in long-range kissing interactions with a
conserved cis-acting element located in the coding sequence
of the NS5B protein (named 5BSL3.2) (Friebe et al. 2005;
Diviney et al. 2008; You and Rice 2008), and it has been
shown that these interactions are absolutely required for
RNA replication (You and Rice 2008). Since both types
of kissing interactions (homodimeric, between two HCV
RNA genomes, or heterodimeric, a cis-interaction with the
5BSL3.2 stem–loop within a single RNA genome) involve
the same DLS region, they are likely to be mutually ex-
clusive. It is possible that the DLS region might thus func-
tion as a molecular switch, influencing processes such as
replication, translation, and/or packaging, all of which in-
volve the same plus-strand genomic RNA. As infection
progresses within a cell, the abundance of both genomic
RNA and HCV core protein increase, thereby potentially
favoring formation of the homodimeric RNA conforma-
tion over the monomolecular interaction of the DLS with
the 5BSL3.2 sequence. We envision a model in which the
sequestration of the DLS region in the duplex dimer with
another genomic RNA molecule (promoted through the
action of the core protein) excludes the DLS sequence from
the long-range kissing interaction with the 5BSL3.2 CRE
required for RNA replication, thus leading to inhibition of
RNA replication and perhaps promoting packaging of the
viral RNA. It is also possible that the homodimeric in-
teraction has no positive role in the viral life cycle but
rather may have evolved as a ‘‘brake’’ on viral replication,
so as to maintain a relatively low overall abundance of viral
RNA and viral proteins within infected hepatocytes, which
might in turn favor escape from immunologic surveillance
and long-term persistence of the virus.
It is interesting to note that the genome of GB virus B
(GBV-B), the only other member of the Hepacivirus genus
within which HCV is classified, is also capable of dimeric
conformation in the presence of its core protein (Ivanyi-
Nagy et al. 2006, 2008). This suggests that dimerization of
genomic RNA is a common feature of the Hepacivirus
genus. Since the core proteins of other related viruses (such
as West Nile virus, a member of the Flavivirus genus, and
bovine viral diarrhea virus, a member of the Pestivirus
genus) also exhibit RNA chaperone functions (Ivanyi-Nagy
et al. 2008), it is interesting to speculate that genomic
dimerization might be a feature shared more broadly
among other genera within the family Flaviviridae.
Conclusions
In this study we analyzed the HCV 39-UTR and its in-
volvement in the genomic RNA dimerization. Our results
indicate that the mechanism of dimerization involves the
formation of a kissing complex intermediate, which is con-
verted to a more stable duplex conformation by the core
protein. We show that dimerization is not absolutely es-
sential for viral RNA replication or infectious virus pro-
duction, and propose a model according to which the HCV
DLS region might function as a molecular switch operated
through kissing interactions to regulate the timing of dif-
ferent HCV life cycle events, such as replication, packaging,
and/or viral protein translation.
MATERIALS AND METHODS
RNA samples
A series of RNA oligonucleotides (the 55-nt wild-type X55 RNA,
related mutated forms used in the fluorescence spectroscopy
studies, X55_C31 and X55_C31_U5 RNAs, mutated 16-nt
DLS_C9 RNA, and 55-nt DLS_AA, DLS_UU and DLS_AU) were
transcribed as previously described (Milligan et al. 1987; Milligan
and Uhlenbeck 1989) from synthetic DNA templates in vitro
using the T7 RNA polymerase. RNAs were purified by 10%
polyacrylamide, 8 M urea gel electrophoresis, recovered by
electrophoretic elution, and dialyzed against either 1 mM caco-
dylic acid (pH 6.5) or 10 mM Tris (pH 7.5). Unless otherwise
specified, all RNA samples were annealed prior to use by heating
for 5 min at 95°C, followed by snap-cooling on ice.
HCV core peptide
The full-length 191 amino acid HCV core protein contains three
basic domains (Cristofari et al. 2004; Ivanyi-Nagy et al. 2006). The
first two basic domains, comprising amino acid residues 2–23 and
38–74, were combined to form a 58 amino acid sequence core
peptide, which was named the 2BD core peptide (Ivanyi-Nagy
et al. 2006). The core 2BD peptide was chemically synthesized and
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purified by the Peptide Synthesis Unit at the University of
Pittsburgh, Center for Biotechnology and Bioengineering. The
peptide was reconstituted in 1 mM cacodylic acid (pH 6.5) at
a final concentration of 618 mM.
Native gel electrophoresis
Individual wild-type RNAs, or mixtures of RNAs (such as labeled
and unlabeled samples used in fluorescence spectroscopy assays),
were diluted to 20 mM concentrations. Following annealing, the
RNA samples were incubated either in the absence of MgCl2 or in
the presence of 10 mM MgCl2, at 22°C (temperature at which
a kissing complex conformation is maintained) or at 55°C
(temperature that promotes the formation of the duplex confor-
mation; see Results) for 2.5 h. The samples were electrophoresed
on a 10% native gel in either TBE (Tris Borate EDTA) buffer or
TBM (Tris Borate Magnesium) buffer at 4°C. To study the effect
of the 2BD core peptide on the magnesium treated samples, the
peptide was directly added to the RNA, followed by incubation for
30 min at room temperature. These samples were subsequently
treated with proteinase K for peptide digestion (concentration of
190 mg/mL) for 1 h prior to being run on native gels. The native
gels were run at 4°C, 100 V for 1.5 h and were visualized by
ultraviolet shadowing at 254 nm using an AlphaImager HP
(AlphaInnotech).
Fluorescence spectroscopy
Experiments were performed on a J.Y. Horiba Fluoromax-3
fluorimeter equipped with variable temperature control. The
excitation wavelength was set at 310 nm, and the emission spectra
were recorded from 330–450 nm. All experiments were performed
at 22°C.
RNA kissing complex formation
Two distinct RNAs were constructed for the fluorescence spec-
troscopy assay that analyzes the dimerization of X55 RNA:
X55_G30_31AP, which contained a point mutation (U/G) at
position 30, and in which the highly fluorescent purine analog 2
amino purine (2AP) replaced the adenine at position 31, and
X55_C31, which contained a point mutation (A/C) at position
31 (Fig. 4A). These point mutations prevented the homodimeri-
zation of the RNA constructs but allowed their heterodimeriza-
tion. Similarly, to analyze the interactions of the full-length X
RNA, X98_G30_31AP was constructed, which contained a point
mutation (U/G) at position 30 and in which 2AP replaced the
adenine at position 31. For the analysis of the interactions between
X55 and the isolated DLS region, DLS_C9 was constructed, which
contains a point mutation (A/C) at position 9 (equivalent to
position 31 in X55 of full-length X RNA). The 2AP labeled
samples (55-nt X55_G30_31AP and X55_C31_52AP, as well as the
full-length 98-nt X98_C31_31AP) were chemically synthesized
and purified by Dharmacon.
The dissociation constant of the kissing complex formed by X55
RNA was determined by titrating a fixed concentration of the
fluorescent X55_G30_31AP (500 nM) in 1 mM cacodylic acid (pH
6.5) containing 10 mM MgCl2 with increasing concentrations of
X55_C31. The kissing complex dissociation constant was de-
termined by fitting the binding curve to Equation 1:
F = 1+
IB
IF
1
 
3

Kd + X55 G30 31AP½ t
 

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q 
2  X55 G30 31AP½ t
;
ð1Þ
in which IB and IF are the steady-state fluorescence intensities of
the free and bound X55_G30_31AP, [X55_G30_31AP]t is the total
concentration of X55_G30_31AP RNA, and [X55_C31]t is the
total concentration of X55_C31 RNA.
X55 RNA kissing complex to duplex conversion
To analyze the formation of the X55 duplex conformation in the
presence of the HCV core protein by fluorescence spectroscopy,
two additional RNAs were constructed: X55_G30_52AP, which
retained the point mutation (U/G) at position 30 and in which
2AP was introduced in the stem region as a single bulged
nucleotide at position 52, and its complementary RNA construct
X55_C31_U5, which retained the point mutation (A/C) at
position 31 and had a uracil inserted at position 5 (Fig. 5B).
These mutated constructs are not able to homodimerize but
can heterodimerize. The structural isomerization of X55 RNA
was monitored by preforming the kissing complex between
X55_G30_52AP and X55_C31_U5 (100 nM each) in the presence
of 10 mM MgCl2 and 140 mM KCl, and monitoring the decrease
of the 2AP steady-state fluorescence upon the addition of an
excess (500 nM) of the 2BD core peptide. All conversion curves
were corrected by subtracting the contribution of the peptide
background. The kissing complex to duplex conversion rate was
determined using Equation 2:
Ft = F1  exp kconv  tð Þ+ F2  exp karrtð Þ+C; ð2Þ
where kconv is the observed isomerization rate for conversion of
the DLS kissing complex to extended mature duplex dimer, and
karr is attributed to the rate of rearrangement of the 2-AP probe
subsequent to its stacking in the duplex conformation (Rist and
Marino 2002; Mihailescu and Marino 2004).
HCV replication analysis
pH77Sv3 is an improved version of pH77S, a plasmid containing
the genome-length sequence of the genotype 1a H77 strain of
HCV with five cell culture-adaptive mutations that promote its
replication in Huh7 hepatoma cells (Yi and Lemon 2004; Yi et al.
2006). pH77Sv3GLuc2A is a related construct in which GLuc
sequence, fused to the 2A auto-catalytic protease of foot-and-
mouth virus RNA (Yi et al. 2002), was inserted in-frame between
p7 and NS2 (Shimakami et al. 2009). RNAs transcribed from both
plasmids contain authentic 59- and 39-terminal UTR sequences of
genotype 1a virus and produce infectious virus when transfected
into Huh7 hepatoma-derived cells. Mutations were made within
the DLS sequence in both parental constructs using the Quick-
Change mutagenesis kit in combination with conventional DNA
cloning methods (Stratagene). Wild-type and mutant plasmid
DNAs were linearized by XbaI digestion followed by in vitro
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transcription using the MEGAscript kit (Ambion). Following
digestion with RNase-free DNase to remove template DNA,
RNA was purified using the RNAeasy Mini Kit (Qiagen), and
RNA transfection was carried out using the Trans-IT mRNA
transfection kit (Mirus) according to the manufacturer’s suggested
protocol. Briefly, 250 ng RNA was transfected to 8 3 104 cells/well
in 24-well plates. Beginning 9 h after transfection, and at 24-h
intervals thereafter, the medium of cultures transfected with the
GLuc RNA constructs was replaced with fresh medium. Secreted
GLuc activity was measured in 25-mL aliquots of these cell culture
supernatant fluids using the Gaussia Luciferase Assay Kit (New
England Biolabs). The luminescent signal was measured on
a Synergy 2 (Bio-Tek) microplate reader. GLuc activity was
normalized to that present at 9 h to control for transfection
efficiency.
Infectious virus titers were determined by enumerating foci of
infected cells in naı¨ve Huh-7.5 cells inoculated with dilutions of
supernatant fluids from H77Sv3 RNA-transfected cultures. The
cells were examined for virus-specific immunofluorescence after
staining for core antigen expression using an indirect labeling
method, as described (Yi et al. 2006).
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